KY19334

KY19334 is an inhibitor of CXXC5-DVL. By blocking the interaction between CXXC5 and Dvl, KY19334 activates the Wnt/β-catenin signaling pathway. It also hinders the proliferation, migration, invasion, and transformation of cancer cells through CDK1 inhibition. Moreover, KY19334 accelerates wound healing and promotes regeneration. This compound is applicable in research related to cancer, inflammation, neurological, and metabolic disorders, such as skin squamous cell carcinoma and diabetes.